A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults by Haranaka, Miwa, Baber, James, Ogama, Yoichiro, Yamaji, Masako, Aizawa, Masakazu, Kogawara, Osamu, Scully, Ingrid, Lagkadinou, Eleni, Türeci, Ӧzlem, Şahin, Uğur, Dormitzer, Philip R., Gruber, William C., Lockhart, Stephen

Get full text

Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of EPI‐589 in Healthy Participants by Noda, Naoto, Hamatani, Tatsuto, Shibue, Yuta, Takagaki, Takeshi, Kitamura, Atsushi, Haranaka, Miwa, Ogama, Yoichiro, Kakuyama, Hiroyoshi

Get full text

Phase 1 Clinical Trial of PPMX‐T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics by Ogama, Yoichiro, Kumagai, Yuji, Komatsu, Norio, Araki, Marito, Masubuchi, Nami, Akiyoshi, Hiroko, Matsuura, Tadashi, Kirisako, Hiromi, Kyoya, Akiko, Nomura, Fumiko, Ohira, Yuta, Yokokawa, Takuya, Yamamoto, Yukiya

Get full text

A randomized dose-escalation study to assess the safety, tolerability, and pharmacokinetics of ruxolitinib (INC424) in healthy Japanese volunteers by Ogama, Yoichiro, Mineyama, Tomoko, Yamamoto, Asuka, Woo, Margaret, Shimada, Naomi, Amagasaki, Taro, Natsume, Kazuto

Get full text

Effects of a reactive oxygen species generator, napabucasin (BBI608), on tolerability, safety, pharmacokinetics, and QT/QTc interval in healthy volunteers by Noda, Naoto, Takagaki, Takeshi, Yodo, Yasuhide, Horibuchi, Yuzo, Iino, Shuichi, Matsuki, Shunji, Ogama, Yoichiro, Kakuyama, Hiroyoshi

Get full text

Loss or down‐regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts by Masuda, Kozo, Hiraki, Akio, Fujii, Nobuharu, Watanabe, Toshiyuki, Tanaka, Motoyuki, Matsue, Kosei, Ogama, Yoichiro, Ouchida, Mamoru, Shimizu, Kenji, Ikeda, Kazuma, Tanimoto, Mitsune

Request full text

Effect of Milk on the Pharmacokinetics of Oseltamivir in Healthy Volunteers by Morimoto, Kaori, Kishimura, Kozue, Nagami, Takaaki, Kodama, Nao, Ogama, Yoichiro, Yokoyama, Midori, Toda, Shinya, Chiyoda, Takeshi, Shimada, Rieko, Inano, Akihiro, Kano, Takashi, Tamai, Ikumi, Ogihara, Takuo

Get full text

Pharmacokinetics and safety of CT-P17 (40 mg/0.4 ml) versus reference adalimumab: randomized study in healthy Japanese adults by Haranaka, Miwa, Tanaka, Takanori, Kim, SungHyun, Bae, YunJu, Jeon, DaBee, Choi, EunJin, Cha, JungBin, Lee, SangMi, Ogama, Yoichiro

Get full text

Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas by OKA, Takashi, OUCHIDA, Mamoru, KONDO, Eisaku, TAKAHASHI, Kiyoshi, TSUCHIYAMA, Junjiro, TANIMOTO, Mitsune, SHIMIZU, Kenji, AKAGI, Tadaatsu, KOYAMA, Maho, OGAMA, Yoichiro, TAKADA, Shinichi, NAKATANI, Yoko, TANAKA, Takehiro, YOSHINO, Tadashi, HAYASHI, Kazuhiko, OHARA, Nobuya

Get full text

Safety and Pharmacokinetics of Ruxolitinib (INC424) in Healthy Japanese Volunteers: Placebo-Controlled, Double-Blind, Dose-Escalation Phase 1 Study by Ogama, Yoichiro, Mineyame, Tomoko, Yamamoto, Asuka, Shimada, Naomi, Amagasaki, Taro, Natsume, Kazuto

Get full text

Multiple splicing variants of Naf1/ABIN-1 transcripts and their alterations in hematopoietic tumors by Shiote, Yasuhiro, Ouchida, Mamoru, Jitsumori, Yoshimi, Ogama, Yoichiro, Matsuo, Yoshinobu, Ishimaru, Fumihiko, Tanimoto, Mitsune, Shimizu, Kenji

Get full text